Serial Number
99545486
Owner
PathAI, Inc.Attorney
Gabriel M. GillmeyerFirst Use Date
May 29, 2024
Filing Date
Dec 12, 2025
IHCEXPLORE Trademark
Serial Number: 99545486
Trademark Classes
Class 9 - Computers & Electronics
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Class 42 - Computer & Scientific
Scientific and technological services; industrial analysis and research services
Class 44 - Medical Services
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Owner Contact Info
Legal Representation
Correspondence Address
Gabriel M. Gillmeyer Ropes & Gray LLP
Prudential Tower, 800 Boylston Street
Boston, MA 02199
United States
Trademark Details
Filing Date
December 12, 2025
Registration Date
Not Registered
First Use Anywhere
May 29, 2024
First Use in Commerce
May 29, 2024
Goods & Services
Downloadable scientific and medical data via the internet; downloadable pathology data for use in medical and scientific research
Analyzing and compiling pathology data and providing reports in connection therewith; Analyzing and compiling data for research purposes in the fields of pathology, medical science, and pharmaceutical consultancy and providing reports in connection therewith; Analyzing and compiling data for medical and scientific research and analytical purposes in the fields of pathology, medical science, and pharmaceutical consultancy and providing reports in connection therewith; Providing medical and scientific data analytics analysis and providing a website featuring non-downloadable software using artificial intelligence for analyzing medical and scientific data in the pathology field for the purpose of research and development; Providing an internet website portal featuring medical and scientific research information and downloadable data in the fields of pathology, medical science, and pharmaceutical consultancy
Providing medical information to oncology drug developers in the form of reports in the field of pathology; providing medical information to oncology drug developers in the form of reports in the field of pathology, medical science, and pharmaceutical consultancy